… of COVID-19 are varied and … markers that become altered in COVID-19 patients and their
impact on different organs at a hepatic, cardiac, renal and pancreatic level, as well as markers …

… alterations in patients with COVID‐19 compared with uninfected controls in this study.
Our results refine the molecular view of COVID‐19 pathophysiology associated with disease …

… In Tables 1, 2, we compared NLR to other reported markers for COVID-19. We seperated
the variables into those that have been reported for COVID-19 diagnosis and disease severity. …

… test results from 28 COVID-19 patients. The concentrations of 6 serum biochemical markers
showed significant differences between severe and mild COVID-19 patients. Interestingly, …

… syndrome coronavirus 2 (SARS-CoV-2), emerged in Wuhan, China, leading to the outbreak
of an unusual viral pneumonia known as coronavirus disease 2019 (COVID-19). COVID-19 …

… of novel Coronavirus Disease 2019 (nCOVID-19). A novel virus, severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus pandemic 2019. …

… acute COVID-19 showed activation of inflammatory markers during the … function were normal,
whereas clinical symptoms were independent of both inflammatory and pulmonary markers …

… In this article, we aim to assess oxidative stress markers in Covid-19 patients compare to the
… Covid-19 patients showed high serum level of oxidative stress and inflammatory markers …

… -19. The associations of increased ALT, AST, ALP, and TBIL … associated with adverse
outcomes of COVID-19 (Table 2 and … of liver function with 28-day mortality of COVID19 using …

… The study population included 456 patients with COVID‑19, confirmed by the reverse … and
prognosis of patients with COVID‑19. AST appears to be a more sensitive marker than alanine …